We are live on ! Find out more
BSPM

Biostar Pharmaceuticals, Inc.
BSPM

Delisted

BSPM was delisted on the 18th of September, 2018.

Back to rankings

8 hedge funds and large institutions have $324K invested in Biostar Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

33% more funds holding

Funds holding: 6 → 8 (+2)

36% less capital invested

Capital invested by funds: $506K → $324K (-$182K)

Holders
8
Holders Change
+2
Holders Change %
+33.33%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$32K
2
VKH
Virtu KCG Holdings
New York
+$11.7K
3
Renaissance Technologies
Renaissance Technologies
New York
+$7.28K
4
Morgan Stanley
Morgan Stanley
New York
+$17

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$380

BSPM Hedge Fund Activity: Q4 2015 in Review

8 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Biostar Pharmaceuticals, Inc. (BSPM) for Q4 2015, worth a combined $324K — down 36% from $506K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new BSPM positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $32K. The largest seller was UBS Group, cutting an estimated $380.

  • 8 institutional investors held Biostar Pharmaceuticals, Inc. (BSPM) as of Q4 2015, up from 6 in Q3 2015.
  • Funds reported $324K of Biostar Pharmaceuticals, Inc. stock for Q4 2015, down 36% quarter-over-quarter.
  • 2 funds opened new Biostar Pharmaceuticals, Inc. positions in Q4 2015 and 0 closed out, a net change of +2 holders.
  • The largest Biostar Pharmaceuticals, Inc. buyer in Q4 2015 was Citadel Advisors, an estimated $32K added.
  • The largest Biostar Pharmaceuticals, Inc. seller in Q4 2015 was UBS Group, an estimated $380 sold.

Based on aggregated 13F filings for Q4 2015.